“A cure might help, but it won't erase it all”: a qualitative study of policy challenges and priorities for long‐term survivors of HIV in the United States
Journal of the International AIDS Society · 2025
DOI: 10.1002/jia2.70006 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Ali Ahmed und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Health Policy, HIV Long-Term Survivors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Introduction
Long‐term survivors (LTS) of HIV, including individuals diagnosed before the availability of effective antiretroviral therapy (ART), have played a pivotal role in shaping the HIV response. Despite an increase in their number in the United States, their unique medical, social and economic challenges remain underrepresented in HIV policy and research, particularly in the context of HIV cure advancements. While an HIV cure may alleviate ART‐related burdens, LTS fear unintended consequences, including the potential loss of critical social benefits, economic support and healthcare access. This study explores the policy priorities of LTS, addressing their current unmet needs and the broader implications of an HIV cure.
Methods
We conducted qualitative interviews with 32 LTS across diverse racial, gender and geographic backgrounds, recruited through community‐based organizations and research networks from 2023 to 2024. Using inductive thematic analysis, we identified key policy concerns and recommendations based on participants’ lived experiences. Data collection continued until thematic saturation was reached.
Results
LTS emphasized four pressing policy domains: (1) Persistent Healthcare Disparities: Participants reported fragmented Medicare and Medicaid coverage, limited access to essential services (e.g. dental, vision and mental healthcare), and ongoing stigma and discrimination in healthcare settings. (2) Social and Economic Precarity: Housing instability, financial insecurity and employment barriers disproportionately affect LTS, many of whom face systemic barriers to re‐entering the workforce. (3) Policy Implications of an HIV Cure: Participants voiced concerns that an HIV cure, while promising, could result in disqualification from disability and social assistance programmes, exacerbating socio‐economic vulnerabilities. (4) Structural Reforms for LTS Inclusion: LTS underscored the urgent need for their direct involvement in HIV research, policy development and decision‐making to ensure equitable, community‐driven solutions.
Conclusions
Policymakers must address comprehensive healthcare access, economic stability and social protections for LTS of HIV. HIV cure research must not undermine existing benefits or widen disparities. Ensuring LTS representation in decision‐making is critical to developing equitable policies that safeguard their wellbeing before and after a cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, California, USA.
- HIV + Aging Research Project - Palm Springs (HARP-PS), Palm Springs, California, USA.
- Reversing Immune Dysfunction for HIV-1 (RID-HIV) Eradication Martin Delaney Collaboratory Community Engagement Coordination and Community Advisory Board, San Diego, California, USA.
- Long-Term Survivor of HIV, Nationawide, USA.
- University of Washington Center for AIDS Research (CFAR), Seattle, Washington, USA.
- Delaney AIDS Research Enterprise (DARE) Martin Delaney Collaboratory Community Engagement Coordination and Community Advisory Board, San Francisco, California, USA.
ORCID-Profile: Ali Ahmed, Thomas J Villa, Karine Dubé
Förderung
- NIAID NIH HHS
Zitieren
APA
Ahmed, A., Taylor, J., Lau, R., Lai, J. C., Deshan Diunugala, S., Louella, M., Villa, T. J., Freshwater, W., Averitt, D., Karris, M., Berry, J., Dee, L., & Dubé, K. (2025). “A cure might help, but it won't erase it all”: a qualitative study of policy challenges and priorities for long‐term survivors of HIV in the United States. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.70006
Vancouver
Ahmed A, Taylor J, Lau R, Lai JC, Deshan Diunugala S, Louella M, et al. “A cure might help, but it won't erase it all”: a qualitative study of policy challenges and priorities for long‐term survivors of HIV in the United States. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.70006
BibTeX
@article{Ahmed2025,
author = {Ahmed, Ali and Taylor, Jeff and Lau, Rachel and Lai, Joyce Ching-Jung and Deshan Diunugala, Sithara and Louella, Michael and Villa, Thomas J and Freshwater, William and Averitt, Dawn and Karris, Maile and Berry, Jeff and Dee, Lynda and Dubé, Karine},
title = {“A cure might help, but it won't erase it all”: a qualitative study of policy challenges and priorities for long‐term survivors of HIV in the United States},
journal = {Journal of the International AIDS Society},
year = {2025},
doi = {10.1002/jia2.70006}
}
EUVIMED